194 related articles for article (PubMed ID: 20463834)
21. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
[TBL] [Abstract][Full Text] [Related]
22. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
Maxwell EL; Palme CE; Freeman J
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
[TBL] [Abstract][Full Text] [Related]
23. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
Evans HL; Vassilopoulou-Sellin R
Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
[TBL] [Abstract][Full Text] [Related]
24. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.
Mills SC; Haq M; Smellie WJ; Harmer C
Eur J Surg Oncol; 2009 Mar; 35(3):230-4. PubMed ID: 18722077
[TBL] [Abstract][Full Text] [Related]
25. Hürthle cell tumors: a twenty-five-year experience.
Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
[TBL] [Abstract][Full Text] [Related]
26. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
27. [Follicular carcinoma and Hürthle cell tumor of the thyroid].
Miccoli P; Arganini M
Chir Ital; 1994; 46(4):29-32. PubMed ID: 7882439
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma.
Ernaga Lorea A; Migueliz Bermejo I; Anda Apiñániz E; Pineda Arribas J; Toni García M; Martínez de Esteban JP; Insausti Serrano AM
Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918
[TBL] [Abstract][Full Text] [Related]
29. [Benign thyroid oncocytomas. Outcome after more than 4 years].
Gailleton R; Lorand I; Bedossa P; Chaumerliac P; Gayral F
Presse Med; 1995 Mar; 24(12):563-6. PubMed ID: 7770401
[TBL] [Abstract][Full Text] [Related]
30. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
31. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
[TBL] [Abstract][Full Text] [Related]
32. Malignant potential of small oncocytic follicular carcinoma/Hürthle cell carcinoma: an institutional experience.
Samulski TD; Bai S; LiVolsi VA; Montone K; Baloch Z
Histopathology; 2013 Oct; 63(4):568-73. PubMed ID: 23952654
[TBL] [Abstract][Full Text] [Related]
33. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
34. Be Aware of the Patient With Benign Follicular Thyroid Lesion Histology and Rising Thyroglobulin Level.
Slutzky-Shraga I; Sternov Y; Robenshtock E; Tzvetov G; Benbassat C; Hirsch D
Endocr Pract; 2018 Aug; 24(8):740-745. PubMed ID: 30106632
[TBL] [Abstract][Full Text] [Related]
35. Hürthle cell adenoma of the thyroid: in 32 consecutive cases.
Guadagni S; Francavilla S; Agnifili A; De Bernardinis G; Mariani G; Carboni M
J R Coll Surg Edinb; 1996 Aug; 41(4):246-9. PubMed ID: 8772075
[TBL] [Abstract][Full Text] [Related]
36. [Predictive factors for malignancy in Hürthle-cell thyroid neoplasia. Effect of surgical treatment].
Pisanu A; Aste L; Piu S; Cois A; Uccheddu A
Tumori; 2003; 89(4 Suppl):223-5. PubMed ID: 12903600
[TBL] [Abstract][Full Text] [Related]
37. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
38. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
[TBL] [Abstract][Full Text] [Related]
39. Hürthle cell lesions in thyroid neoplasms.
Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
[TBL] [Abstract][Full Text] [Related]
40. Hürthle cell tumors of the thyroid gland.
Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
